Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet

K Vervier, S Moss, N Kumar, A Adoum, M Barne… - Gut, 2022 - gut.bmj.com
Objective Reducing FODMAPs (fermentable oligosaccharides, disaccharides,
monosaccharides and polyols) can be clinically beneficial in IBS but the mechanism is …

[PDF][PDF] Prevalence of viral hepatitis (B and C) serological markers in healthy working population

JL Calleja-Panero, E Llop-Herrera… - Rev Esp Enferm …, 2013 - scholar.archive.org
Introduction and objectives: prevalence of viral hepatitis (B and C) changes geographically.
Our aim was to determinate the prevalence of hepatitis B (HBV) and hepatitis C virus (HCV) …

[HTML][HTML] Biologic therapy for inflammatory bowel disease: Real-world comparative effectiveness and impact of drug sequencing in 13 222 patients within the UK IBD …

C Kapizioni, R Desoki, D Lam… - Journal of Crohn's …, 2023 - academic.oup.com
Abstract Background and Aims This study compares the effectiveness of different biologic
therapies and sequences in patients with inflammatory bowel disease [IBD] using real-world …

[HTML][HTML] A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE) …

NM Noor, JC Lee, S Bond, F Dowling… - The Lancet …, 2024 - thelancet.com
Background Management strategies and clinical outcomes vary substantially in patients
newly diagnosed with Crohn's disease. We evaluated the use of a putative prognostic …

[PDF][PDF] Prevalencia de marcadores serológicos de virus hepatotropos (B y C) en población trabajadora sana

JL Calleja-Panero, E Llop-Herrera… - Revista Española de …, 2013 - SciELO Espana
Resumen CALLEJA-PANERO, José Luis et al. Prevalence of viral hepatitis (B and C)
serological markers in healthy working population. Rev. esp. enferm. dig.[online]. 2013, vol …

[HTML][HTML] Predicting outcomes for Crohn's disease using a molecular biomarker: profile trial

N Noor, B Brezina, JDLR Negro, F Dowling… - Clinical …, 2022 - ncbi.nlm.nih.gov
Methods From a training cohort of 69 newly diagnosed IBD patients, we simultaneously
obtained a whole-blood PAXgene® RNA tube and peripheral-blood CD8 T-cell sample …

Effect of season and sunlight on viral kinetics during hepatitis C virus therapy

N Hernández-Alvarez, JMP Acevedo… - BMJ Open …, 2017 - bmjopengastro.bmj.com
Background and aims Rapid viral response (RVR) during antiviral treatment for hepatitis C
virus (HCV) predicts sustained viral response (SVR). Recently, vitamin D levels have been …

P228 Evaluation of clinical features influencing outcome in patients with microscopic colitis

A Agorogianni, A Hadjinicolaou, F Shah, B Bonelli… - Gut, 2022 - search.proquest.com
Methods Our population included all patients with microscopic colitis identified from the
Addenbrooke's hospital electronic medical records (EPIC) between 2014 and 2021. The …

IDDF2020-ABS-0183 PROFILE trial: predicting outcomes for Crohn's disease using a molecular biomarker

N Noor, B Brezina, JDLR Negro, F Dowling, L O'Brien… - 2020 - gut.bmj.com
Background The course of IBD varies substantially between individuals, but there are a lack
of reliable prognostic markers to guide clinical practice. Previously, we have described a …

Should HCV-Positive Asymptomatic Patients with Mixed Cryoglobulinemia Be Treated with Combined Antiviral Therapy?

JLC Panero, J de la Revilla Negro… - HCV Infection and …, 2012 - Springer
Mixed cryoglobulinemia (MC) is a lymphoproliferative disorder resulting from
immunoglobulin complexes that precipitate in serum in the cold. The disease is associated …